AU4213100A - Dsp-4 dual-specificity map kinase phosphatase - Google Patents
Dsp-4 dual-specificity map kinase phosphataseInfo
- Publication number
- AU4213100A AU4213100A AU42131/00A AU4213100A AU4213100A AU 4213100 A AU4213100 A AU 4213100A AU 42131/00 A AU42131/00 A AU 42131/00A AU 4213100 A AU4213100 A AU 4213100A AU 4213100 A AU4213100 A AU 4213100A
- Authority
- AU
- Australia
- Prior art keywords
- dsp
- dual
- map kinase
- kinase phosphatase
- specificity map
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03016—Phosphoprotein phosphatase (3.1.3.16), i.e. calcineurin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12820499P | 1999-04-07 | 1999-04-07 | |
US60128204 | 1999-04-07 | ||
PCT/US2000/009313 WO2000060099A1 (en) | 1999-04-07 | 2000-04-07 | Dsp-4 dual-specificity map kinase phosphatase |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4213100A true AU4213100A (en) | 2000-10-23 |
Family
ID=22434173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU42131/00A Abandoned AU4213100A (en) | 1999-04-07 | 2000-04-07 | Dsp-4 dual-specificity map kinase phosphatase |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1171614A1 (en) |
JP (1) | JP2002540795A (en) |
AU (1) | AU4213100A (en) |
CA (1) | CA2367109A1 (en) |
WO (1) | WO2000060099A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6903800A (en) * | 1999-08-13 | 2001-03-13 | Sugen, Inc. | Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
AU2001247782A1 (en) * | 2000-03-24 | 2001-10-08 | Millennium Pharmaceuticals, Inc. | 18221, dual specificity phosphatase and uses thereof |
US20030232441A1 (en) * | 2002-06-17 | 2003-12-18 | Isis Pharmaceuticals Inc. | Antisense modulation of dual specific phosphatase 4 expression |
-
2000
- 2000-04-07 WO PCT/US2000/009313 patent/WO2000060099A1/en not_active Application Discontinuation
- 2000-04-07 CA CA002367109A patent/CA2367109A1/en not_active Abandoned
- 2000-04-07 EP EP00921870A patent/EP1171614A1/en not_active Withdrawn
- 2000-04-07 JP JP2000609589A patent/JP2002540795A/en not_active Withdrawn
- 2000-04-07 AU AU42131/00A patent/AU4213100A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2367109A1 (en) | 2000-10-12 |
WO2000060099A1 (en) | 2000-10-12 |
EP1171614A1 (en) | 2002-01-16 |
JP2002540795A (en) | 2002-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002367366A1 (en) | System for communicating through maps | |
AU2001237041A1 (en) | Kinase inhibitors | |
AU1844001A (en) | Web map tool | |
AU6471300A (en) | P38map kinase inhibitors | |
AU6483299A (en) | Ampic dram | |
AU2001258784A1 (en) | Tyrosine phosphatase inhibitors | |
AUPQ416699A0 (en) | Depth map compression technique | |
AU7136200A (en) | Range measuring system | |
AU6355700A (en) | Dsp-11 dual-specificity map kinase phosphatase | |
AU4658400A (en) | Dsp-10 dual-specificity map kinsase phosphatase | |
AU2001238048A1 (en) | Mammalian sphingosine-1-phosphate phosphatase | |
AU4683200A (en) | Dsp-5 dual-specificity map kinase phosphatase | |
AU1772101A (en) | Capacitor development | |
AU4213100A (en) | Dsp-4 dual-specificity map kinase phosphatase | |
AU4470200A (en) | Dsp-8 dual-specificity map kinase phosphatase | |
AU4210100A (en) | Dsp-7 dual-specificity map kinase phosphatase | |
AU4079400A (en) | Dsp-9 dual-specificity map kinase phosphatase | |
AU4020000A (en) | Dsp-2 dual-specificity map kinase phosphatase | |
AU7708000A (en) | Phosphatases which activate map kinase pathways | |
AU6164800A (en) | Level sensor-switch | |
AU1800700A (en) | Ikk3 kinase | |
AU4206700A (en) | Dsp-3 dual-specificity phosphatase | |
AU2001282234A1 (en) | CDC25 phosphatase inhibitors | |
AU2001291146A1 (en) | Dsp-15 dual-specificity phosphatase | |
AU2001238651A1 (en) | Pyridine-amidines as modulators of p38 map kinase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |